TrialCancer chemotherapy and pharmacology2014

First-in-human phase II trial of the botanical formulation PHY906 with capecitabine as second-line therapy in patients with advanced pancreatic cancer.

Muhammad Wasif Saif et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.